Search for: "Watson Pharmaceuticals Inc."
Results 141 - 160
of 225
Sorted by Relevance
|
Sort by Date
13 Dec 2010, 11:41 am
©2010 Amaxx Risk Solutions, Inc. [read post]
26 Mar 2010, 12:33 pm
By alerting readers to disputes like this one (and the one yesterday at BioMarin Pharmaceutical, Inc.), we’re not attempting to determine which side in these disputes is “right. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
15 Jun 2011, 4:56 am
Watson Pharmaceuticals, Inc. et al. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive… [read post]
15 Jul 2011, 11:32 pm
Watson??? [read post]
15 Jul 2011, 11:32 pm
Watson??? [read post]
22 Jun 2011, 4:09 am
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s Amendment (and… [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
3 May 2011, 6:30 am
In addition, following the submission of one of the Foundation’s proposals (to Watson Pharmaceuticals, Inc.), the company announced a plan to bring a declassification proposal to a vote at its 2011 annual meeting. [read post]
6 Dec 2010, 10:56 am
©2010 Amaxx Risk Solutions, Inc. [read post]
25 Jun 2013, 9:51 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
1 Nov 2011, 6:08 am
Inc. have experienced problems. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
9 May 2011, 6:07 am
Albers Medical, Inc., 395 F. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
